MedTrace Logo

A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device

NCT04569318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-11-24

No results posted yet for this study

Summary

Single arm proof-of-concept trial to evaluate the safety and efficacy of the REVISYON PoC Device in the treatment of cataract.

Conditions

  • Cataract

Interventions

DEVICE

Treatment Beam

One of the subject's eyes will be treated with the treatment beam (20mW) up to 8 times for 15 minutes.

Sponsors & Collaborators

  • Onorach Clinical

    collaborator UNKNOWN

  • Edinburgh Biosciences Ltd

    lead INDUSTRY

Principal Investigators

  • Chief Executive · Edinburgh Biosciences Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2021-08-19
Completion
2021-09-09

Countries

  • Latvia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04569318 on ClinicalTrials.gov